Diagnostics Pipeline: To Gain Insight into Haystack MRD Test, Quest Works with City of Hope
New liquid biopsy assay will be used in conjunction with 500 cancer patients currently enrolled in clinical trials
New liquid biopsy assay will be used in conjunction with 500 cancer patients currently enrolled in clinical trials
From – Diagnostic Testing & Emerging Technologies
The US Preventive Services Task Force (USPSTF) issued updated recommendations for BRCA-related cancer risk assessment…
From – Diagnostic Testing & Emerging Technologies
The clinical value of performing multigene panel for inherited cancer in patients with metastatic breast cancer has…
From – Diagnostic Testing & Emerging Technologies
Developing a cost-effective blood test capable of accurately detecting early Alzheimer’s disease that can be…
From – Diagnostic Testing & Emerging Technologies
The T2Bacteria Panel (T2Biosystems; Lexington, Mass.) can rapidly and accurately diagnoses bloodstream infections (BSIs) caused by…